A sensitive method for the simulataneous determination of bufuralol and its pharmacologically active metabolites in huamn plasma is described. The O-timethylsilyl,N-trifluoroacetyl derivatives are assayed by mass fragmentography. Sensitivity is 1 ng 76(-1) plasma for bufaralol and about 250 pg ml(-1
Determination of midazolam and its α-hydroxy metabolite in plasma by gas chromatography with electron capture detection
✍ Scribed by Heizmann, P. ;von Alten, R.
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- English
- Weight
- 250 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0935-6304
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A sensitive GC‐ECD assay has been developed for the simultaneous determination of midazolam (I) and its α‐hydroxy metabolite (II) in plasma. The assay involves extraction of both compounds into ether at alkaline pH (pH 12), followed by silylation of the α‐hydroxy metabolite with N,O‐bis(trimethylsilyl) trifluoroacetamide (BSTFA). On extracting 0.5 ml of plasma, the sensitivity limits are 4ng/ml for I and 3ng/ml for II. If present, the minor urinary metabolites, the 4‐hydroxy (III) and the α,4‐dihydroxy compound (IV), can also be determined by this method.
📜 SIMILAR VOLUMES
## Abstract A sensitive gas liquid chromatographic (GLC) assay was developed for plasma determinations of 8‐chloro‐6‐(2′ ‐fluorophenyl)‐1‐methyl‐4__H__‐imidazo[1,5 α][1,4]benzodiazepine (compound I) and its hydroxymethylimidazo metabolite (compound II). The internal standards used were 8‐chloro‐6‐(
A rapid, sensitive, and reliable method for the determination of nifedipine in human plasma is described. Using a single-step solvent extraction and capillary gas chromatography combined with electron capturedetection, an assaysensitivityof 2 ng/ml is achieved routinely using 0.5 ml of plasma. Intac